Study finds women are two to three times more likely to be affected than men.
Women in low- and middle-income countries, especially in the Sub-Saharan Africa region, may be 10 times more likely to have obesity or heart health issues than their male counterparts, according to a large meta-analysis published in The Journal of Clinical Endocrinology and Metabolism.
Obesity is a chronic disease characterised by an individual having an excess of body fat or abnormal fat accumulation. People who have obesity are at an increased risk for other serious diseases and health conditions.
Obesity kills at least 2.8 million people per year, yet the public still does not recognise it as a disease, and anti-obesity medications are still under prescribed and hard to access. Obesity is preventable, but according to the World Health Organization, the disease has nearly tripled since 1975. In 2016, 52% of adults and over 340 million children and teens were considered to have be overweight or have obesity.
Our findings are important as they call for urgent actions targeting obesity awareness, prevention, treatment, and control in women in low- and middle-income countries.
The researchers included 3,916,276 people in the meta-analysis and found obesity does not manifest evenly across women and men in low- and middle-income countries, with women being 2-3 times more likely to be affected than men. They found the greatest disparity in the risk of obesity between women and men is in the Sub-Saharan region, where women are up to 10 times more likely to have obesity than men.
For the first time, we are able to assess the extent of poor metabolic health faced by women compared to men in low- and middle-income countries. Funders and policymakers need to implement woman-centred measures addressing the underlying social, cultural and behavioural factors to improve their long-term metabolic health.
The authors shared a few examples of the factors contributing to the higher rate of obesity in these women including:
The other authors of this study are Eka Melson of the University of Birmingham; Javier Zamora of the University of Birmingham, Hospital Universitario Ramón y Cajal (IRYCIS) and the CIBERESP Instituto de Salud Carlos III in Madrid, Spain; Borja Fernandez-Felix of the CIBERESP Instituto de Salud Carlos III; and Wiebke Arlt of the Medical Research Council Laboratory of Medical Sciences and Imperial College London, U.K.
The study was funded by the Wellcome Trust and the NIHR Birmingham Biomedical Research Centre.
Honorary Professor
Staff profile of Professor Shakila Thangaratinam, Honorary Professor at Metabolism and Systems Science (MSS) at the University of Birmingham.
Honorary Clinical Research Fellow
Staff profile of Dr Eka Melson, Honorary Clinical Research Fellow in the Department of Metabolism and Systems Science (MSS) at the University of Birmingham.
Professor of Biostatistics in Maternal and Perinatal Health
Staff profile for Professor Javier Zamora, Professor of Biostatistics in Maternal and Perinatal Health in the Institute of Metabolism and Systems Research (IMSR), University of Birmingham.
Honorary Professor
Staff profile of Professor Wiebke Arlt, Honorary Professor at the Department of Metabolism and Systems Research, University of Birmingham.
